Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007.

Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D. · 2009

Read Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. by Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2683932.txt.

Introduction

Sabuncu and colleagues, led in reporting by Guillemot's group, evaluated in 2009 a nationwide French campaign to cut needless antibiotic use. France had faced rising drug-resistant pneumococci, the germ behind many chest and ear infections, fed by heavy prescribing. The campaign, run from 2002, urged doctors and the public to save antibiotics for when they truly help.

The evaluation found a significant drop in community antibiotic use over the five years to 2007. The fall was sharpest in prescriptions for children, the group most often given antibiotics for viral colds that the drugs cannot cure. Cutting use matters because resistance follows consumption: the more a germ meets a drug, the faster resistant strains spread. France's result, the authors argue, shows a coordinated national push, repeated each winter, can change prescribing habits at population scale.

Catalog record

CREATORSabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2683932

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007 By Elifsu Sabuncu, Julie David, Claire Bernède-Bauduin, Sophie Pépin, Michel Leroy, Pierre-Yves Boëlle, Laurence Watier, Didier Guillemot, Keith P Klugman Published in: PLoS Medicine DOI: 10.1371/journal.pmed.1000084 ABSTRACT Didier Guillemot and colleagues describe the evaluation of a nationwide programme in France aimed at decreasing unnecessary outpatient prescriptions for antibiotics. The campaign was successful, particularly in reducing prescriptions for children. INTRODUCTION The emergence and the dissemination of drug-resistant bacterial strains make treatment decisions challenging and may be associated with treatment failures. This phenomenon has become a major public health issue. Streptococcus pneumoniae is the most commonly identified bacterial cause of community-acquired invasive infections and pneumonia [1],[2]. Multidrug-resistant pneumococci (MRP) are now ubiquitous, despite the recent availability and now wide use of 7-valent pneumococcal conjugate vaccine (7-PCV) in developed countries, with more infections being caused by nonvaccine serotypes [3]. Very few new antimicrobial drugs are expected to become available in the near future, and several studies support the notion that antibiotic consumption is a key driving force in the rate (number of resistant isolates/total number of isolates) of beta-lactam–resistant pneumococci [4] and in the dissemination of MRP [5]–[7]. Furthermore, there is some evidence that decreasing antibiotic use can lower MRP rates [8]. For instance, the highest MRP rates are reported in southern Europe [9], southeastern Asia [10], and North America [11], where antibiotic consumption is generally higher than in northern Europe [12]. Thus, many countries have undertaken public health programs to optimize antibiotic prescriptions in the community [13]. In the early 2000s, France, a country with nearly 62,000,000 inhabitants and nearly 54,000 general practitioners, faced growing problems with MRP, with >50% of strains showing decreased penicillin G susceptibility. France was also identified as the country with the highest antibiotic consumption in Europe [12] and one of the highest antimicrobial users worldwide. Thus, the French government initiated a long-term nationwide campaign to reduce antibiotic overuse and control the dissemination of resistant bacteria in the community. The national program, named “Keep Antibiotics Working,” was launched in 2001, targeting both the general public and health care professionals, to encourage surveillance of antibiotic use and resistance and to promote better-targeted antibiotic use. Since 2002, a public service campaign entitled “Les antibiotiques c'est pas automatique” (“Antibiotics are not automatic”) is launched each winter with the primary goal of decreasing prescriptions, particularly during the viral respiratory infection (VRI) epidemic season and among children, for whom >40% of the prescriptions are written [14]–[16]. In this article we evaluate the effectiveness of these campaigns by analyzing the evolution of outpatient antibiotic use in France from 2000 to 2007, for each therapeutic class, as well as by geographic and age-group patterns. We performed a time-series analysis and accounted for flu-like syndrome (FLS) variations. METHODS The Campaign (“Antibiotics Are Not Automatic”) In 2002 the French National Health Insurance (NHI) launched a long-term nationwide campaign in the community. From its conception, the aim of the campaign was to decrease total antibiotic use in the community by 25%, targeting predominantly VRIs in young children. An extensive information dissemination campaign was developed with the central theme “Antibiotics are not automatic.” Each winter (October–March) it is relaunched, as higher levels of infections and prescriptions occur during this period. A description of the campaign is detailed in Text S1. Definitions and Data Sources The NHI program covers all medical care provided by physicians in private practice, community clinics, and hospitals. Patients pay health service fees, which are refunded by the NHI. In France, everyone, even those with low or no income, are covered by the NHI program. We used anonymous computerized individual data from two main NHI agencies (General Scheme and Social Scheme), which cover salaried workers and the self-employed (≥91% of the French population), to access all antibiotics prescribed, dispensed by outpatient pharmacies, and reimbursed by NHI from 2000 to 2007 (beginning week 27 [July] 2000, ending week 13 [March] 2007). Each drug approved by the French Drug Agency is assigned a unique seven-digit code that enables identification of a particular product and its specific dosage, package size, formulation, and manufacturer. Each file contains this drug-related information, prescription date, patient's sex, year of birth, and region of residence. Weekly FLS incidence was provided by the French Sentinel Network [17] (see http://sentiweb.org/). According to the French Sentinel Network, FLS is defined as the combination of the following clinical symptoms: sudden onset fever ≥39°C, myalgia, and respiratory symptoms such as dyspnea and/or cough. Demographic data were obtained from the French National Institute for Statistics and Economic Studies (INSEE, http://www.insee.fr). We included the European part of France (henceforth referred to as France), which accounts for 83% of French territory and 96% of its population. For each of France's 22 administrative regions, reimbursement data were extrapolated to 100% of the regional population by dividing the number of prescriptions by the corresponding region's NHI coverage rate. The results are presented as the weekly rate of antibiotic prescriptions per 100 inhabitants. The study concerns antibiotics for systemic use (anatomical therapeutic class [ATC] code J01) in the community. Antibiotics were divided into six categories according to the ATC classification: penicillins, cephalosporins, macrolides, quinolones, cyclines, and “other.” Statistical Analysis Our analysis describes the crude number of antibiotic prescriptions and FLS incidence over time, overall, and by region, antibiotic class, and age group (0–5, 6–15, >15 y). We focused on the period targeted by the public service campaign (October–March); more specifically, we examined the truncated series corresponding to a 26-wk period starting at week 40 of year n and finishing at week 13 of year n+1. We conducted time-series analyses to quantitatively evaluate the impact of the successive, annual campaigns on antibiotic consumption. We used intervention models [18]–[20] that allowed us to estimate crude and FLS-adjusted effects of the campaign. The intervention models were built in two steps. For the first step, we chose the 2000–2002 period preceding the first campaign, i.e., starting at week 27 in 2000 and ending at week 40 in 2002, as the baseline and fitted a model to the series of antibiotic prescriptions accounting for seasonal variations and underlying autoregressive and moving average processes. As in other southern and eastern European countries [21], antibiotic consumption in France shows marked yearly seasonal fluctuations; therefore we first estimated a periodic trigonometric function and removed it from the truncated series so that the residual series was in stationary mode. We then fitted an autoregressive and moving average (ARMA) model [22] on the residual series, leaving white noise residual series. For the second step, we assumed that observations before and after the campaign were drawn from the same ARMA model with changes only in the mean. Following this assumption, we removed the previously estimated periodic trigonometric function from the whole antibiotic prescription series (2000–2007) and added five dummy variables, one for each annual campaign, to the ARMA model identified in step 1 so that only the mean could change. We quantified the impact of each campaign as the average relative change for the period (from winter 2002–2003 to winter 2006–2007) compared with baseline (2000–2002); that is, the ratio of the observed change over the expected change predicted from the model

Read the complete text